4 results
Approved WMOCompleted
The objective is to determine whether ITB Therapy is more effective than oral anti-spasticity agents in reducing the spasticity.
Approved WMOCompleted
To investigate whether ticagrelor increases adenosine receptor stimulation in humans in vivo by ENT inhibition.
Approved WMOCompleted
Please refer to protocol, section 1.2 "Rationale"
Approved WMOCompleted
The current study is being conducted to determine whether long-term dual-antiplatelet therapy with ticagrelor in combination with ASA (recommended daily dose 75-100 mg) is beneficial in patients with history of MI (1-3 years ago) and additional risk…